H.R. 573 · 111th Congress
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
- Stage
- In committee
- Sponsor
- Jo Ann Emerson
- Introduced
- 2009-01-15
- Latest action
- 2009-01-16 · Referred to the Subcommittee on Health.
Subjects
Health
Prescription drugs
Drug safety, medical device, and laboratory regulation